SCHEMBL8862032

SCHEMBL8862032

COc1ccc(CCCCCCCCO)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.63
IGF1R P08069 1/20 0.61
ALOX15 P16050 1/20 0.61
CYP4F2 P78329 1/20 0.56
CYP4A11 Q02928 1/20 0.56
TDP1 Q9NUW8 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
TAAR1 Q96RJ0 1/20 0.53
ALOX5 P09917 1/20 0.53
F2RL1 P55085 1/20 0.50
GAA P10253 1/20 0.49
MEN1 O00255 1/20 0.49
USP2 O75604 1/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
CYP3A4 P08684 1/20 0.49
MAPK1 P28482 1/20 0.49
CASP1 P29466 1/20 0.49
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4740749 1.00 CALM1 (0.63) CALM1IGF1RALOX15CYP4F2CYP4A11
SCHEMBL8413383 1.00 CALM1 (0.63) CALM1IGF1RALOX15CYP4F2CYP4A11
SCHEMBL1171813 0.98 CALM1 (0.66) CALM1IGF1RALOX15CYP4F2CYP4A11
SCHEMBL79113 0.92 CALM1 (0.68) CALM1IGF1RALOX15CYP4A11TAAR1
SCHEMBL10571532 0.89 CALM1 (0.69) CALM1IGF1RALOX15TDP1L3MBTL1
SCHEMBL17400406 0.89 CALM1 (0.69) CALM1IGF1RALOX15TDP1L3MBTL1
SCHEMBL9509173 0.89 CALM1 (0.69) CALM1IGF1RALOX15TDP1L3MBTL1
SCHEMBL11007798 0.89 CALM1 (0.69) CALM1IGF1RALOX15TDP1L3MBTL1
SCHEMBL28218193 0.89 CALM1 (0.69) CALM1IGF1RALOX15TDP1L3MBTL1
SCHEMBL4254058 0.87 CALM1 (0.72) CALM1IGF1RALOX15TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5656636-A TREATING PSORIASIS SMITHKLINE BEECHAM CORPORATION (US) 1997-08-12 US disclosed
US-5633258-A Pyridine compounds for treating leukotriene-related diseases SMITHKLINE BEECHAM CORPORATION (US) 1997-05-27 US disclosed
US-5631262-A Pyridine compounds for treating leukotriene-related diseases SMITHKLINE BEECHAM CORPORATION (US) 1997-05-20 US disclosed
EP-0675718-A1 SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS LEUKOTRIENE ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1995-10-11 EP disclosed
EP-0675718-A4 SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS LEUKOTRIENE ANTAGONISTS. SMITHKLINE BEECHAM CORP (US) 1995-08-22 EP disclosed
WO-1994014797-A1 QUINOLINE COMPOUNDS AND THE TREATMENT OF LEUCOTRIENE RELATED DISEASES THEREWITH SMITHKLINE BEECHAM CORPORATION (US) 1994-07-07 WO disclosed
WO-1994014442-A1 SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS LEUKOTRIENE ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1994-07-07 WO disclosed
EP-0604529-A1 PYRIDINE COMPOUNDS FOR TREATING LEUKOTRIENE-RELATED DISEASES SMITHKLINE BEECHAM CORPORATION (US) 1994-07-06 EP disclosed
WO-1993022285-A1 LEUKOTRIENE ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1993-11-11 WO disclosed
WO-1993011768-A1 PYRIDYL COMPOUNDS FOR PSORIASIS TREATMENT SMITHKLINE BEECHAM CORPORATION (US) 1993-06-24 WO disclosed
WO-1993006085-A1 PYRIDINE COMPOUNDS FOR TREATING LEUKOTRIENE-RELATED DISEASES SMITHKLINE BEECHAM CORPORATION (US) 1993-04-01 WO disclosed